

Although psoriatic arthritis and rheumatoid arthritis are both common types of inflammatory arthritis characterised by synovial inflammation, there are distinct molecular and cellular landscapes between these conditions. Recent advances in synovial research in psoriatic arthritis have begun to unlock important insights into disease pathogenesis and potential clinical applications. For example, studies using high-dimensional technologies have identified psoriatic arthritis-specific macrophage, fibroblast, and mast cell subsets, as well as specific cytokines, such as IL-36 and IL-41, that drive pathogenesis.
Rheumatology
|31st Dec, 2025
|Journal of the American Medical Association
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet